PMC:7126544 / 61339-61491 JSONTXT

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T24302","span":{"begin":23,"end":35},"obj":"Chemical"},{"id":"T23295","span":{"begin":45,"end":56},"obj":"Chemical"},{"id":"T39647","span":{"begin":66,"end":78},"obj":"Chemical"},{"id":"T28090","span":{"begin":141,"end":152},"obj":"Chemical"}],"attributes":[{"id":"A35480","pred":"chebi_id","subj":"T24302","obj":"http://purl.obolibrary.org/obo/CHEBI_63611"},{"id":"A48568","pred":"chebi_id","subj":"T23295","obj":"http://purl.obolibrary.org/obo/CHEBI_29007"},{"id":"A66344","pred":"chebi_id","subj":"T39647","obj":"http://purl.obolibrary.org/obo/CHEBI_2955"},{"id":"A64192","pred":"chebi_id","subj":"T28090","obj":"http://purl.obolibrary.org/obo/CHEBI_33281"}],"text":"ial therapy, including moxifloxacin (64.4%), ceftriaxone (24.6%), azithromycin (18.1%). In Guan's study, 632 patients were given intravenous antibiotics"}

{"project":"LitCovid-PubTator","denotations":[{"id":"1564","span":{"begin":109,"end":117},"obj":"Species"},{"id":"1567","span":{"begin":23,"end":35},"obj":"Chemical"},{"id":"1568","span":{"begin":45,"end":56},"obj":"Chemical"},{"id":"1569","span":{"begin":66,"end":78},"obj":"Chemical"}],"attributes":[{"id":"A1564","pred":"tao:has_database_id","subj":"1564","obj":"Tax:9606"},{"id":"A1567","pred":"tao:has_database_id","subj":"1567","obj":"MESH:D000077266"},{"id":"A1568","pred":"tao:has_database_id","subj":"1568","obj":"MESH:D002443"},{"id":"A1569","pred":"tao:has_database_id","subj":"1569","obj":"MESH:D017963"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"ial therapy, including moxifloxacin (64.4%), ceftriaxone (24.6%), azithromycin (18.1%). In Guan's study, 632 patients were given intravenous antibiotics"}